CSPC PHARMA (01093) announced that on October 17, 2025, the trustee purchased a total of 3 million company shares in the market in accordance with the terms and conditions of the share award plan, holding these shares in trust for the benefit of selected participants.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.